Braxia Scientific Announces Change in Directors and CEO
| MLSS Stock | USD 0.93 0.02 2.11% |
Slightly above 62% of Milestone Scientific's investor base is looking to short. The analysis of overall sentiment of trading Milestone Scientific stock suggests that many investors are alarmed at this time. Milestone Scientific's investing sentiment can be driven by a variety of factors including economic data, Milestone Scientific's earnings reports, geopolitical events, and overall market trends.
Milestone | Build AI portfolio with Milestone Stock |
Toronto, Ontario-- - Braxia Scientific Corp. announced that Jerry Habuda has resigned as a director effective November 12, 2024. Peter Rizakos was appointed on the same date by the remaining directors. Roger McIntyre resigned as a director and CEO effective November 13, 2024. The current directors of the Company are Ahmed Shehata and Peter Rizakos. About Braxia Scientific ...
Read at finance.yahoo.com
 |
Milestone Scientific Fundamental Analysis
We analyze Milestone Scientific's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Milestone Scientific using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Milestone Scientific based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Milestone Scientific is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Milestone Scientific Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Milestone Scientific stock to make a market-neutral strategy. Peer analysis of Milestone Scientific could also be used in its relative valuation, which is a method of valuing Milestone Scientific by comparing valuation metrics with similar companies.
Peers
Milestone Scientific Related Equities
| PAVM | PAVmed | 4.41 | ||||
| SSKN | STRATA Skin | 3.66 | ||||
| INFU | InfuSystems Holdings | 2.05 | ||||
| RVP | Retractable Technologies | 1.33 | ||||
| OCX | OncoCyte Corp | 2.09 |
Additional Tools for Milestone Stock Analysis
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.